Procyanidins and Alzheimer's Disease

Overview

Journal Mol Neurobiol

Specialties Molecular Biology
Neurology

Date 2019 Jan 17

PMID 30649713

Citations 32

Authors

Siqi Zhao

Li Zhang

Chenlu Yang

Zhenghua Li

Shuang Rong

Affiliations

Soon will be listed here.

Abstract

Procyanidins, the oligomeric compounds formed from catechin and epicatechin molecules, are potentially effective targets as nutraceuticals or pharmaceuticals in the prevention and treatment of Alzheimer's disease (AD). Natural procyanidins can attenuate AD pathological features, extracellular amyloid deposits, and neurofibrillary tangles via reducing Aβ accumulation and tau pathology. The enhancement of cognition as well as modulation of synaptic plasticity by these compounds also participated in the alleviation of AD. Notably, procyanidins and some of their metabolites have been observed to upregulate SIRT1 (silent information regulator 1) which is essential for normal cognitive and synaptic plasticity, and stimulate CREB (cAMP response element binding) which acts as a molecular switch from short- to long-term memory. Based on the interplay of CREB-SIRT1 axis, it is therefore conceivable that the regulation of procyanidins by the means of CREB-SIRT1 could promote the cognitive function and is thus conducive for AD pathogenesis. This review focuses on the role of procyanidins, the main group of flavonoids, on AD and the potential mechanism involved CREB-SIRT1 axis.

Citing Articles

Insights Into the Therapeutic Potential of SIRT1-modifying Compounds for Alzheimer's Disease: A Focus on Molecular Mechanisms.

AlHayani D, Kubaev A, Uthirapathy S, Mandaliya V, Ballal S, Kalia R J Mol Neurosci. 2025; 75(1):29.

PMID: 40000535 DOI: 10.1007/s12031-025-02324-9.

Histone Deacetylation in Alzheimer's Diseases (AD); Hope or Hype.

Ateya N, Al-Taie S, Jasim S, Uthirapathy S, Chaudhary K, Rani P Cell Biochem Biophys. 2025; .

PMID: 39825060 DOI: 10.1007/s12013-025-01670-0.

Investigation of oligomeric proanthocyanidins extracted from Rhodiolae Crenulatae Radix et Rhizomes using deep eutectic solvents and identified via data-dependent acquisition mass-spectroscopy.

Jia L, Wang L, Zhang X, Zhang Q, Lei P, Chang Y J Pharm Anal. 2025; 14(11):101002.

PMID: 39759969 PMC: 11697046. DOI: 10.1016/j.jpha.2024.101002.

Alzheimer's Disease, Obesity, and Type 2 Diabetes: Focus on Common Neuroglial Dysfunctions (Critical Review and New Data on Human Brain and Models).

Toledano A, Rodriguez-Casado A, Alvarez M, Toledano-Diaz A Brain Sci. 2024; 14(11).

PMID: 39595866 PMC: 11591712. DOI: 10.3390/brainsci14111101.

Harnessing the Anti-Inflammatory Properties of Polyphenols in the Treatment of Inflammatory Bowel Disease.

Boaru D, Fraile-Martinez O, De Leon-Oliva D, Garcia-Montero C, De Castro-Martinez P, Miranda-Gonzalez A Int J Biol Sci. 2024; 20(14):5608-5672.

PMID: 39494333 PMC: 11528451. DOI: 10.7150/ijbs.98107.

References

Meisterernst M . Mechanisms of transcriptional activation of cAMP-responsive element-binding protein CREB. Mol Cell Biochem. 2000; 212(1-2):5-9. View

Asahara H, Santoso B, Guzman E, Du K, Cole P, Davidson I . Chromatin-dependent cooperativity between constitutive and inducible activation domains in CREB. Mol Cell Biol. 2001; 21(23):7892-900. PMC: 99956. DOI: 10.1128/MCB.21.23.7892-7900.2001. View

Kida S, Josselyn S, Pena de Ortiz S, Kogan J, Chevere I, Masushige S . CREB required for the stability of new and reactivated fear memories. Nat Neurosci. 2002; 5(4):348-55. DOI: 10.1038/nn819. View

Vitolo O, SantAngelo A, Costanzo V, Battaglia F, Arancio O, Shelanski M . Amyloid beta -peptide inhibition of the PKA/CREB pathway and long-term potentiation: reversibility by drugs that enhance cAMP signaling. Proc Natl Acad Sci U S A. 2002; 99(20):13217-21. PMC: 130613. DOI: 10.1073/pnas.172504199. View

Alarcon J, Malleret G, Touzani K, Vronskaya S, Ishii S, Kandel E . Chromatin acetylation, memory, and LTP are impaired in CBP+/- mice: a model for the cognitive deficit in Rubinstein-Taybi syndrome and its amelioration. Neuron. 2004; 42(6):947-59. DOI: 10.1016/j.neuron.2004.05.021. View

Wood M, Kaplan M, Park A, Blanchard E, Oliveira A, Lombardi T . Transgenic mice expressing a truncated form of CREB-binding protein (CBP) exhibit deficits in hippocampal synaptic plasticity and memory storage. Learn Mem. 2005; 12(2):111-9. PMC: 1074328. DOI: 10.1101/lm.86605. View

Devi A, Jolitha A, Ishii N . Grape seed proanthocyanidin extract (GSPE) and antioxidant defense in the brain of adult rats. Med Sci Monit. 2006; 12(4):BR124-9. View

Mantena S, Katiyar S . Grape seed proanthocyanidins inhibit UV-radiation-induced oxidative stress and activation of MAPK and NF-kappaB signaling in human epidermal keratinocytes. Free Radic Biol Med. 2006; 40(9):1603-14. DOI: 10.1016/j.freeradbiomed.2005.12.032. View

Schroeter H, Bahia P, Spencer J, Sheppard O, Rattray M, Cadenas E . (-)Epicatechin stimulates ERK-dependent cyclic AMP response element activity and up-regulates GluR2 in cortical neurons. J Neurochem. 2007; 101(6):1596-606. DOI: 10.1111/j.1471-4159.2006.04434.x. View

10.

Geraets L, Moonen H, Brauers K, Wouters E, Bast A, Hageman G . Dietary flavones and flavonoles are inhibitors of poly(ADP-ribose)polymerase-1 in pulmonary epithelial cells. J Nutr. 2007; 137(10):2190-5. DOI: 10.1093/jn/137.10.2190. View

11.

Wang J, Ho L, Zhao W, Ono K, Rosensweig C, Chen L . Grape-derived polyphenolics prevent Abeta oligomerization and attenuate cognitive deterioration in a mouse model of Alzheimer's disease. J Neurosci. 2008; 28(25):6388-92. PMC: 2806059. DOI: 10.1523/JNEUROSCI.0364-08.2008. View

12.

Wayman G, Davare M, Ando H, Fortin D, Varlamova O, Cheng H . An activity-regulated microRNA controls dendritic plasticity by down-regulating p250GAP. Proc Natl Acad Sci U S A. 2008; 105(26):9093-8. PMC: 2449370. DOI: 10.1073/pnas.0803072105. View

13.

Karuppagounder S, Pinto J, Xu H, Chen H, Beal M, Gibson G . Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease. Neurochem Int. 2008; 54(2):111-8. PMC: 2892907. DOI: 10.1016/j.neuint.2008.10.008. View

14.

Julien C, Tremblay C, Emond V, Lebbadi M, Salem Jr N, Bennett D . Sirtuin 1 reduction parallels the accumulation of tau in Alzheimer disease. J Neuropathol Exp Neurol. 2008; 68(1):48-58. PMC: 2813570. DOI: 10.1097/NEN.0b013e3181922348. View

15.

Hebert S, De Strooper B . Alterations of the microRNA network cause neurodegenerative disease. Trends Neurosci. 2009; 32(4):199-206. DOI: 10.1016/j.tins.2008.12.003. View

16.

Nudelman A, DiRocco D, Lambert T, Garelick M, Le J, Nathanson N . Neuronal activity rapidly induces transcription of the CREB-regulated microRNA-132, in vivo. Hippocampus. 2009; 20(4):492-8. PMC: 2847008. DOI: 10.1002/hipo.20646. View

17.

Xu J, Rong S, Xie B, Sun Z, Zhang L, Wu H . Rejuvenation of antioxidant and cholinergic systems contributes to the effect of procyanidins extracted from the lotus seedpod ameliorating memory impairment in cognitively impaired aged rats. Eur Neuropsychopharmacol. 2009; 19(12):851-60. DOI: 10.1016/j.euroneuro.2009.07.006. View

18.

Krikorian R, Nash T, Shidler M, Shukitt-Hale B, Joseph J . Concord grape juice supplementation improves memory function in older adults with mild cognitive impairment. Br J Nutr. 2009; 103(5):730-4. DOI: 10.1017/S0007114509992364. View

19.

Xu J, Rong S, Xie B, Sun Z, Zhang L, Wu H . Procyanidins extracted from the lotus seedpod ameliorate age-related antioxidant deficit in aged rats. J Gerontol A Biol Sci Med Sci. 2010; 65(3):236-41. DOI: 10.1093/gerona/glp211. View

20.

Endres K, Fahrenholz F . Upregulation of the alpha-secretase ADAM10--risk or reason for hope?. FEBS J. 2010; 277(7):1585-96. DOI: 10.1111/j.1742-4658.2010.07566.x. View